Breaking News Bar

Business News and Information

Active Pharmaceutical Ingredients Market 2018 Global Share, Trend And Opportunities Forecast To 2026

Active Pharmaceutical Ingredients Industry


Wiseguyreports.Com Adds “Active Pharmaceutical Ingredients -Market Demand, Growth, Opportunities and Analysis Of Top Key Player Forecast To 2026” To Its Research Database

Global Active Pharmaceutical Ingredients Market is accounted for $151.89 billion in 2017 and is expected to reach $308.48 billion by 2026 growing at a CAGR of 8.2% from 2017 to 2026. Increase in incidence of chronic diseases, rising prevalence of cancer, technological advancements in API manufacturing, growing importance of generics, rapidly increasing geriatric population, increase in abbreviated new drug applications (ANDA) and increasing uptake of biopharmaceuticals are some factors fueling the market growth. However, factors such as stringent regulatory requirements and unfavorable drug price control policies across various countries are restricting the market growth. 

Active pharmaceutical ingredients are any substance or combination of substances used in a finished pharmaceutical product with pharmacological activity. Active Pharmaceutical Ingredients are chemically and biologically active components of drugs with direct effect in cure, mitigation, treatment and prevention of diseases. An active ingredient (AI) is the ingredient in a pharmaceutical drug that is biologically active. The similar terms active pharmaceutical ingredient (API) and bulk active are also used in medicine, and the term active substance may be used for natural products. Some medication products may contain more than one active ingredient. The traditional word for the API is pharmacon or pharmakon which originally denoted a magical substance or drug. 

Amongst Customer Base, Generic segment accounted for significant market share during the forecast period. Generic drugs benefit from the patent expiration of innovative drug as it makes them readily available in the market. The demand to produce quality medicines at lower and affordable costs creates a scenario, where the needs for generic drugs increase. By geography, Asia Pacific dominated the market due to the rising healthcare spending which has led to quality healthcare becoming accessible along with a higher demand for pharmaceutical products across APAC. The pharmaceuticals consumed here are mostly produced in onshore manufacturing units. Furthermore, contract manufacturing organizations are key outsourcing allies for pharmaceutical companies that supply their wares across the region.

Some of the key players in Active Pharmaceutical Ingredients market include Teva Active Pharmaceutical Industries Limited, Ranbaxy Laboratories, Pfizer, Inc, Novartis, Mylan N.V, Lupin, Dr. Reddy’s Lab, Boehringer Ingelheim GmbH, Aurobindo pharma, Albemarle Corporation, Ceva Animal Health, Inc., Virbac, Sun Pharmaceutical Industries Ltd., Merck Animal Health (U.S.), Elanco Animal Health (U.S.), Zoetis (U.S.), Merial Inc. (Sanofi) (France), Bioniche Animal Health (Canada), Bayer Healthcare (Germany), ELI Lilly and Company, Glaxosmithkline PLC, Abbvie Inc., Sanofi and Bristol-Myers Squibb.

Request for Sample Report @

Drug Types Covered: 
• Generic Prescription 
• Innovative Drugs 
• Over-the-counter (OTC) Drugs 
• Prescription Drugs 
• Potency

API Formulations Covered: 
• Innovative API 
• Generic API

Type of Manufacturers Covered: 
• Contract Manufacturers 
• Captive Manufacturers 
• Merchant API Manufacturers

Type of Synthesises Covered: 
• Biotech Active Pharmaceutical Ingredients 
• Synthetic Active Pharmaceutical Ingredients

API Types Covered: 
• Biological API 
• Chemical API

Molecules Covered: 
• Large Molecule 
• Small Molecule

Applications Covered: 
• Anti-diabetic Drugs 
• Cardiovascular Disease 
• Central Nervous System and Neurological Disorders 
• Diabetes 
• Endocrinology 
• Gastrointestinal Disorders 
• Musculoskeletal drugs 
• Non-steroidal Anti-inflammatory Drugs 
• Oncology 
• Orthopedic Disorders 
• Respiratory 
• Urology 
• Other Applications

Regions Covered: 
• North America 
o US 
o Canada 
o Mexico 
• Europe 
o Germany 
o UK 
o Italy 
o France 
o Spain 
o Rest of Europe 
• Asia Pacific 
o Japan 
o China 
o India 
o Australia 
o New Zealand 
o South Korea 
o Rest of Asia Pacific 
• South America 
o Argentina 
o Brazil 
o Chile 
o Rest of South America 
• Middle East & Africa 
o Saudi Arabia 
o UAE 
o Qatar 
o South Africa 
o Rest of Middle East & Africa

Leave a Query @

What our report offers: 
– Market share assessments for the regional and country level segments 
– Market share analysis of the top industry players 
– Strategic recommendations for the new entrants 
– Market forecasts for a minimum of 9 years of all the mentioned segments, sub segments and the regional markets 
– Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations) 
– Strategic recommendations in key business segments based on the market estimations 
– Competitive landscaping mapping the key common trends 
– Company profiling with detailed strategies, financials, and recent developments 
– Supply chain trends mapping the latest technological advancements


Table of Content

1 Executive Summary 

2 Preface 
2.1 Abstract 
2.2 Stake Holders 
2.3 Research Scope 
2.4 Research Methodology 
2.4.1 Data Mining 
2.4.2 Data Analysis 
2.4.3 Data Validation 
2.4.4 Research Approach 
2.5 Research Sources 
2.5.1 Primary Research Sources 
2.5.2 Secondary Research Sources 
2.5.3 Assumptions 

3 Market Trend Analysis 
3.1 Introduction 
3.2 Drivers 
3.3 Restraints 
3.4 Opportunities 
3.5 Threats 
3.6 Application Analysis 
3.7 Emerging Markets 
3.8 Futuristic Market Scenario 

4 Porters Five Force Analysis 
4.1 Bargaining power of suppliers 
4.2 Bargaining power of buyers 
4.3 Threat of substitutes 
4.4 Threat of new entrants 
4.5 Competitive rivalry 

13 Key Developments 
13.1 Agreements, Partnerships, Collaborations and Joint Ventures 
13.2 Acquisitions & Mergers 
13.3 New Product Launch 
13.4 Expansions 
13.5 Other Key Strategies 

14 Company Profiling 
14.1 Teva Active Pharmaceutical Industries Limited 
14.2 Ranbaxy Laboratories 
14.3 Pfizer, Inc 
14.4 Novartis 
14.5 Mylan N.V 
14.6 Lupin 
14.7 Dr. Reddy’s Lab 
14.8 Boehringer Ingelheim GmbH 
14.9 Aurobindo pharma 
14.10 Albemarle Corporation 
14.11 Ceva Animal Health, Inc. 
14.12 Virbac 
14.13 Sun Pharmaceutical Industries Ltd. 
14.14 Merck Animal Health (U.S.) 
14.15 Elanco Animal Health (U.S.) 
14.16 Zoetis (U.S.) 
14.17 Merial Inc. (Sanofi) (France) 
14.18 Bioniche Animal Health (Canada) 
14.19 Bayer Healthcare (Germany) 
14.20 ELI Lilly and Company 
14.21 Glaxosmithkline PLC 
14.22 Abbvie Inc. 
14.23 Sanofi 
14.24 Bristol-Myers Squibb 

Buy Now @




Tags: , , , , , , , , , , , , , , , , , See Campaign:
Contact Information:
Contact Us: Sales@Wiseguyreports.Com Ph: +1-646-845-9349 (Us)  Ph: +44 208 133 9349 (Uk)

, Research Newswire, Press Release, Private Equity, Venture Capital, Seed funding, IPO, Mergers & Acquisitions, Equity Crowdfunding, Lending, Reward-Donation, Private Companies, Conferences, Public Companies / Stock Exchange Listed Companies, Non-Disclosure, All other, Real Estate, South America, North America, United States, Latin America, United Kingdom, Europe, Africa, Asia, Middle East, English


Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
bottom clear